Search Results1-13 of  13

  • CHAKI Shigeyuki ID: 9000001284564

    Medicinal Pharmacology Laboratory, Taisho Pharmaceutical Co., Ltd. (2004 from CiNii)

    Articles in CiNii:1

    • The Role of the DRY Motif of Human MC4R for Receptor Activation (2004)
  • CHAKI Shigeyuki ID: 9000005285059

    Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd. (1990 from CiNii)

    Articles in CiNii:1

    • ATTENUATION OF SEROTONIN-SUPPRESSED [^3H] ACETYLCHOLINE RELEASE FROM RAT HIPPOCAMPUS BY MINAPRINE : INVOLVEMENT OF 5-HT_2 RECEPTOR AND VOLTAGE-DEPENDENT K^+ CHANNEL (1990)
  • CHAKI Shigeyuki ID: 9000005764567

    Articles in CiNii:12

    • 初代培養神経細胞におけるσ-1受容体を介したσリガンドの細胞内移行 (1996)
    • Antidepressant-like activities of MCL0129, a novel and potent nonpeptide antagonist of the melanocortin-4 receptor (2003)
    • Anxiolytic-like activities of MCL0129 (1-[(S)-2-(4-Fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynapthalen-1-yl)butyl]piperazine), a nonel and potent nonpeptide antagonist of the melanocortin 4 receptor (2003)
  • CHAKI Shigeyuki ID: 9000006426859

    Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd. (2007 from CiNii)

    Articles in CiNii:2

    • Synthesis of Diphenylmethyl Analogues and Their Affinity for the Melanocortin-4 Receptor and the Serotonin Transporter (2007)
    • Identification of Arginine Analogues as Antagonists and Agonists for the Melanocortin-4 Receptor (2007)
  • CHAKI Shigeyuki ID: 9000018537778

    大正製薬株式会社 薬理機能研究所創薬薬理第1研究室 (2010 from CiNii)

    Articles in CiNii:2

    • Preface (2010)
    • 次世代抗うつ薬開発の最前線 (特集 気分障害研究の最前線) (2008)
  • CHAKI Shigeyuki ID: 9000019092826

    Molecular Function and Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd. (2012 from CiNii)

    Articles in CiNii:1

    • The Selective Metabotropic Glutamate 2/3 Receptor Agonist MGS0028 Reverses Isolation Rearing-Induced Abnormal Behaviors in Mice (2012)
  • CHAKI Shigeyuki ID: 9000107371598

    大正製薬株式会社 薬理機能研究所 創薬薬理第1研究室 (2012 from CiNii)

    Articles in CiNii:1

    • 統合失調症治療薬の研究開発序文 (2012)
  • CHAKI Shigeyuki ID: 9000107372606

    大正製薬株式会社薬理機能研究所 創薬薬理第1研究室 (2012 from CiNii)

    Articles in CiNii:1

    • Discovery of novel antipsychotics targeting group II metabotropic glutamate receptor (2012)
  • CHAKI Shigeyuki ID: 9000107388047

    Discovery Pharmacology I, Molecular Function and Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd. (2012 from CiNii)

    Articles in CiNii:1

    • The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant (2012)
  • CHAKI Shigeyuki ID: 9000261039223

    Discovery Pharmacology I, Molecular Function and Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd. (2013 from CiNii)

    Articles in CiNii:1

    • Stimulation of Metabotropic Glutamate (mGlu) 2 Receptor and Blockade of mGlu1 Receptor Improve Social Memory Impairment Elicited by MK-801 in Rats (2013)
  • Chaki Shigeyuki ID: 9000256090820

    Department of Biochemistry and Medicine, Vanderbilt University School of Medicine, (1993 from CiNii)

    Articles in CiNii:1

    • Angiotensin ll receptors: cloning, structure, function and regulation (1993)
  • Chaki Shigeyuki ID: 9000345376403

    Discovery Pharmacology I, Molecular Function and Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd (2014 from CiNii)

    Articles in CiNii:1

    • Group I and group II metabotropic glutamate receptor ligands as novel drugs to treat schizophrenia and depression:the preclinical and clinical evidence (2014)
  • Chaki Shigeyuki ID: 9000367420643

    Pharmacology I, Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd. (2016 from CiNii)

    Articles in CiNii:1

    • Antidepressant effects of group II mGlu receptor antagonists : involvement of mTOR signaling and serotonergic system (2016)
Page Top